We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis.
- Authors
Marth, Christian; Kisic, Jelena; Kærn, Janne; Tropé, Claes; Fodstad, Øystein; Kaern, Janne; Tropé, Claes; Fodstad, Øystein
- Abstract
<bold>Background: </bold>Ovarian carcinoma is apparently restricted for a long time to the peritoneal cavity. However, about 50% of patients with a surgically documented complete intraabdominal response experience later recurrence. Occult hematogenous micrometastases are common to most epithelial malignancies and have recently been found in 30% of bone marrow samples of ovarian carcinoma patients, as examined by immunocytochemistry. Moreover, these findings were associated with poor progression-free and overall survival. The aim of the current study was to evaluate the possible prognostic significance of tumor cells detected in the peripheral blood and bone marrow of ovarian carcinoma patients by an immunomagnetic method.<bold>Methods: </bold>In a total of 90 patients with histologically proven epithelial ovarian carcinoma, blood and (in 73 cases) bone marrow samples were taken. Tumor cells were identified by a microbead coated with the antibody MOC-31, which recognizes an epitope regularly expressed on ovarian carcinoma cells.<bold>Results: </bold>The authors detected carcinoma cells in the bone marrow in 21% of ovarian carcinoma patients, and in the peripheral blood in 12% of patients. Mean overall survival was 25 and 28 months for patients with or without circulating tumor cells, respectively.<bold>Conclusions: </bold>Ovarian carcinoma cells seem to reach peripheral circulation more frequently than expected. However, in contrast to an earlier report, detection of tumor cells in the bone marrow and/or blood was not associated with poor prognosis in ovarian carcinoma patients. This discrepancy remains unexplained, but characterization of circulating ovarian carcinoma cells for their malignant and metastatic capacity is clearly warranted.
- Subjects
OVARIAN tumors; PREDICTIVE tests; METASTASIS; PROGNOSIS; CANCER; IMMUNOASSAY; SURVIVAL analysis (Biometry); BONE marrow; TUMOR antigens
- Publication
Cancer (0008543X), 2002, Vol 94, Issue 3, p707
- ISSN
0008-543X
- Publication type
journal article
- DOI
10.1002/cncr.10250